<DOC>
	<DOCNO>NCT00849108</DOCNO>
	<brief_summary>The main purpose study get information use BMS747158 ( study drug ) , drug small amount radioactivity allow heart imaging , PET scan compare image SPECT . The safety quality image study .</brief_summary>
	<brief_title>Development 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol BMS747158</brief_title>
	<detailed_description>The primary objective study : - To acquire data development one-day rest/stress cardiac PET perfusion image protocol BMS747158 comparable diagnostic image quality two-day rest/stress PET protocol - To assess safety multiple dos BMS747158 The secondary objective study : - To assess PET image parameter image quality follow administration BMS747158 rest stress ( pharmacologic exercise ) day ( different time interval ) 16-48 hour rest injection - To assess feasibility gate cardiac PET image BMS747158 leave ventricular function assessment - To assess agreement one two day rest/stress PET image BMS747158 patient reversible ischemia rest/stress single photon emission compute tomography ( SPECT ) image - To perform preliminary assessment diagnostic accuracy one-day two-day rest/stress PET perfusion image BMS747158 compare invasive coronary angiography compute tomography angiography ( CTA ) detection</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Provide sign IC prior undergo study procedure Be male nonpregnant female , age 18 75 year , inclusive Have : A rest/stress SPECT imaging study ( either exercise pharmacologic stress ) within 21 day enrollment , use 99mTclabeled tracer show reversible ischemia Female patient must : nonlactating , long childbearing potential , either postmenopausal ( define amenorrhea â‰¥ 12 consecutive month , undergone successful surgical sterilization ( hysterectomy , bilateral tubal ligation bilateral oophorectomy ) Presence condition may disrupt and/or increase permeability BBB , include multiple sclerosis , Alzheimer 's disease , Parkinson 's disease , acute central nervous system ( CNS ) infection , CNS tumor , autoimmune disease affect CNS , CNS inflammatory Current significant illness , pathology physical examination vital sign measurementfindings could potentiate adverse pharmacological event associate vasodilatory drug pathology , opinion investigator , might confound interpretation result study Known hypersensitivity adenosine , dipyridamole aminophylline Presence contraindication exercise stress test History New York Heart Association Class III IV Congestive Heart Failure ( CHF ) Any major surgery within 4 week prior enrollment plan within 2 week follow completion 2week telephone followup assessment Inability tolerate IV medication . History drug alcohol abuse within last year Participation investigational drug , device , placebo study within 6 month prior study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Myocardial Perfusion</keyword>
	<keyword>PET image</keyword>
	<keyword>SPECT imaging</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>Subjects male nonpregnant female patient</keyword>
	<keyword>present reversible ischemia characterize</keyword>
	<keyword>rest/stress SPECT imaging study use</keyword>
	<keyword>Technetium ( 99mTc ) -labeled tracer</keyword>
</DOC>